Showing results (61-70 of 75) with videos related to
Sort By:
Pageof 8
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|June 27, 2017
A Study of GWAS-Supported Variants of rs9943582 in a Chinese Han Population with Ischemic Stroke: No Associations with Disease Onset and Clinical OutcomesHao Zhang, Lingli Sun, Huaiming Wang, et al.Journal of Neurointerventional Surgery|November 23, 2022
Effects of admission systemic inflammatory indicators on clinical outcomes in patients with vertebrobasilar artery occlusion: insight from the PERSIST registryPan Zhang, Pengfei Xu, Zuowei Duan, et al.Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|May 1, 2026
Zuojin Pill ameliorates depression with gastrointestinal dysfunction via Parabacteroides distasonisDan Qiao, Yuzhen Huang, Chun Ge, et al.Neurology|December 21, 2019
Renal impairment on clinical outcomes following endovascular recanalizationLulu Xiao, Minmin Ma, Mengmeng Gu, et al.Journal of Neurointerventional Surgery|December 2, 2021
Influence of renal impairment on clinical outcomes after endovascular recanalization in vertebrobasilar artery occlusionsLulu Xiao, Mengmeng Gu, Yijiu Lu, et al.Leukemia & Lymphoma|May 19, 2025
AP2M1 is a prognostic marker associated with cell cycle arrest and the tumor immune microenvironment in acute myeloid leukemiaCe Shi, Yang Li, Xing Zou, et al.Journal of Molecular Neuroscience : MN|December 20, 2018
HDAC9 Polymorphisms Predict Susceptibility, Severity, and Short-Term Outcome of Large Artery Atherosclerotic Stroke in Chinese PopulationMengmeng Wang, Mengmeng Gu, Zibao Li, et al.Journal of Inflammation Research|May 6, 2026
Impact of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor on Immune-Inflammatory Responses in the Acute Phase of Ischemic StrokeZhenzhen Li, Cong Sun, Qing Zhang, et al.Journal of Neurology|June 22, 2022
Initial symptoms of vertebrobasilar artery occlusions and the outcomes after endovascular treatmentJinjing Wang, Shuanggen Zhu, Pengfei Xu, et al.Peerj|January 28, 2026
Impact of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on intracranial atherosclerotic plaque characteristics and low density lipoprotein-cholesterol (LDL-C) reduction: a real-world observational studyZhenzhen Li, Xiaohui Li, Yiting Zhang, et al.Pageof 8